Carmen Sáez

10PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 14, 2025
Efficacy of NAMPT Inhibitors in Pancreatic Cancer After Stratification by MAP17 (PDZK1IP1) Levels.

Eva M Verdugo-Sivianes, Julia Martínez-Pérez, Lola E Navas

|Jul 28, 2025
β-TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1.

Rocío Jiménez-Guerrero, Alejandro Belmonte-Fernández, Mónica González-Moreno

|Mar 26, 2025
Overexpression of βTrCP1 elicits cell death in cisplatin-induced senescent cells.

Alejandro Belmonte-Fernández, Joaquín Herrero-Ruíz, M Cristina Limón-Mortés

|Aug 26, 2023
Parp Inhibitors and Radiotherapy: A New Combination for Prostate Cancer (Systematic Review).

Inés Rivero Belenchón, Carmen Belen Congregado Ruiz, Carmen Saez

|Dec 08, 2022
Cisplatin-induced cell death increases the degradation of the MRE11-RAD50-NBS1 complex through the autophagy/lysosomal pathway.

Alejandro Belmonte-Fernández, Joaquín Herrero-Ruíz, María Galindo-Moreno

|Jun 24, 2022
PARP Inhibitors: A New Horizon for Patients with Prostate Cancer.

Belén Congregado, Inés Rivero, Ignacio Osmán

Pageof 2